PDCD1 and neoplasm: Elevated RIPK1/RIPK3 expression in necroptotic cells activated the NF‐κB‐dependent signals pathway, promoting CD8+ leukocyte‐mediated immune responses, and in combination with anti‐PD‐1 therapy, improved durable tumour clearance.83